October 26, 2026- On Friday, the White House announced changes to Section 338 of the Tariff Act of 1930 to further refine the scope of the tariffs on certain Canadian products previously announced on July 20, 2026 and modified on September 8, 2026. The White House said it would drop tariffs on some Canadian goods, but replace them with other products from the major U.S. trade … [Read more...]
CVS Health collaborates with The Midlife Collective
October 23, 2026- CVS Health® announced a new collaboration with The Midlife Collective, a media company and community platform dedicated to changing the cultural conversation around women and aging. As part of the collaboration, the two organizations will conduct a research study designed to better understand the physical, emotional, social and life experiences of women in … [Read more...]
Intermountain Health Lutheran Breast Care Center earns re-accreditation
October 23, 2026- Intermountain Health Lutheran Hospital Breast Care Center in Wheat Ridge has been re-accredited under the American College of Surgeons (ACS) National Accreditation Program for Breast Centers (NAPBC). Breast cancer is the most common cancer diagnosed in women in the United States after skin cancers. Programs accredited by the NAPBC follow a model for organizing … [Read more...]
FDA launches new program to advance neuroscience medical product development
October 23, 2026- The U.S. Food and Drug Administration announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aimed at delivering breakthrough treatments. NAIN is designed to advance the science, tools, and regulatory approaches needed to support the development of medical products for conditions affecting the brain and nervous … [Read more...]
SEKISUI Diagnostics announces launch of the OSOM® COVID-19/Flu A&B Combo Test
October 23, 2026- SEKISUI Diagnostics has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&B in professional healthcare settings. The OSOM® COVID-19/Flu A&B Combo Test is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and … [Read more...]
UPMC earns recognition for digital innovation
October 23, 2026- UPMC has earned Level 10 recognition, the highest designation awarded through the College of Healthcare Information Management Executives' (CHIME) 2026 Digital Health Most Wired program, placing it among an elite group of health care organizations recognized for excellence in digital health transformation. The distinction is awarded to organizations that … [Read more...]
Amazon, Google sign CMS’ prior authorization pledge
October 22, 2026- The Centers for Medicare & Medicaid Services Oct. 21 announced that Amazon, Axon Enterprise, Inc., Google, Meta and Oracle Corp. are in support of its prior authorization pledge announced last year, according to the American Hospital Association. The pledge involves streamlining prior authorization processes and increasing transparency for patients and … [Read more...]
Medtronic announces positive results from real-world registries for two technologies
October 22, 2026- Medtronic plc announced positive real-world registry results for the Affera™ Mapping and Ablation System with the Sphere-9™ Catheter and the PulseSelect™ Pulsed Field Ablation (PFA) System. The global registry analyses, presented at the Asia Pacific Heart Rhythm Society (APHRS) 2026 scientific meeting, evaluated prospectively enrolled patients with atrial … [Read more...]
INTEGRIS Health to join Risant Health
October 22, 2026- INTEGRIS Health has signed a definitive agreement to become part of Risant Health, a nonprofit organization focused on expanding access to affordable, value-based care. The agreement is subject to regulatory approval. Headquartered in Oklahoma City, INTEGRIS Health operates a statewide network of 10 acute care hospitals, 10 specialty hospitals, physician … [Read more...]
Teleflex announces FDA Breakthrough Device Designation for Freesolve™ RMS device
October 22, 2026- Teleflex Incorporated announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for its Freesolve™ Resorbable Magnesium Scaffold (RMS) for percutaneous coronary intervention (PCI). To qualify for a BDD, device technology must address an unmet clinical need and show that it has the potential to provide for … [Read more...]









